New clinical guidance highlights a shift in gastric cancer treatment from reliance on TNM staging alone to a more individualized approach incorporating biomarker testing. Advances in surgery, ...
Tumor deposits are a significant prognostic factor in colorectal cancer, yet underutilized in N-staging. Ten novel models incorporating tumor deposits showed improved prognostic performance over the ...